Answers are grounded in this paper and cite their sources.
The nomenclature of ‘fatty liver disease’ has undergone yet another change; this time from metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease (MASLD).1 The change in the nomenclature was motivated not by any scientific rationale but by the stigma associated with the terms ‘alcoholic’ and ‘fat’! In this instance, the term ‘fat’ is replaced with ‘steato’. The use of Latin and Greek in scientific communication has become obsolete, as favoring common language aids layman comprehension, a vital consideration from a public health perspective.
No takes yet. Share an insight, caveat, or question.
Sanal Madhusudana Girija (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: